Mieke Gouwy Selected Research

Mieke Gouwy Research Topics

Disease

22	Inflammation (Inflammations) 01/2020 - 02/2005
9	Infections 01/2020 - 07/2004
6	Neoplasms (Cancer) 01/2016 - 11/2003
3	Arthritis (Polyarthritis) 01/2020 - 01/2006
3	Virus Diseases (Viral Diseases) 01/2016 - 11/2010
2	COVID-19 11/2022 - 01/2022
2	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 04/2018 - 01/2017
2	Autoimmune Diseases (Autoimmune Disease) 09/2010 - 09/2008
2	Neoplasm Metastasis (Metastasis) 02/2005 - 11/2003
1	Coinfection 11/2022
1	Human Influenza (Influenza) 11/2022
1	Viral Pneumonia 11/2022
1	Critical Illness (Critically Ill) 11/2022
1	Malaria 01/2022
1	Familial Mediterranean Fever (Periodic Disease) 01/2021
1	Skin Diseases (Skin Disease) 01/2021
1	Staphylococcal Infections 01/2020
1	Acute-Phase Reaction 01/2019
1	Cystic Fibrosis (Mucoviscidosis) 04/2018
1	Respiratory Tract Diseases (Respiratory Tract Disease) 04/2018
1	Epiretinal Membrane (Epiretinal Membranes) 01/2017
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2017
1	Herpes Simplex 01/2016
1	Wounds and Injuries (Trauma) 01/2016
1	Bacterial Infections (Bacterial Infection) 01/2016
1	HIV Infections (HIV Infection) 01/2016
1	Pathologic Processes 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 12/2007
1	Starvation 06/2007
1	Melanoma (Melanoma, Malignant) 06/2007
1	Psoriatic Arthritis 01/2006
1	Ankylosing Spondylitis 01/2006
1	Joint Diseases (Joint Disease) 01/2006
1	Crystal Arthropathies 01/2006
1	Necrosis 01/2006
1	Rheumatoid Arthritis 01/2006
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2003

Drug/Important Bio-Agent (IBA)

22	ChemokinesIBA 11/2022 - 11/2003
8	CytokinesIBA 11/2022 - 12/2005
5	LigandsIBA 04/2018 - 05/2005
3	Chemotactic FactorsIBA 11/2022 - 01/2006
3	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 02/2005
3	Antiviral Agents (Antivirals)IBA 01/2016 - 01/2009
2	Interleukin-17 (Interleukin 17)IBA 11/2022 - 12/2007
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2019 - 01/2016
2	Interleukin-8 (Interleukin 8)IBA 04/2018 - 09/2008
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2018 - 01/2016
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2018 - 02/2005
2	EnzymesIBA 01/2017 - 09/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 06/2007
2	Peptides (Polypeptides)IBA 01/2016 - 10/2008
2	Proteins (Proteins, Gene)FDA Link 12/2015 - 09/2008
2	Peptide Hydrolases (Proteases)FDA Link 01/2006 - 02/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 11/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2022
1	Tissue Inhibitor of MetalloproteinasesIBA 11/2022
1	Secretory Leukocyte Peptidase InhibitorIBA 11/2022
1	ElafinIBA 11/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2022
1	Nelfinavir (Viracept)FDA Link 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	PyrinIBA 01/2021
1	lipoxin A4IBA 01/2020
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2020
1	LipopolysaccharidesIBA 01/2020
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2019
1	PyrogensIBA 01/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	OsteoprotegerinIBA 01/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2017
1	ImmunosorbentsIBA 01/2017
1	GlycosaminoglycansIBA 01/2016
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2016
1	Opsonin Proteins (Opsonins)IBA 01/2016
1	antineoplaston A10 (A 10)IBA 01/2016
1	Anti-Infective Agents (Microbicides)IBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	Chemokine CXCL12IBA 01/2016
1	plerixafor FDA Link 04/2011
1	Maraviroc FDA Link 04/2011
1	Protein Isoforms (Isoforms)IBA 03/2011
1	oxyamylose (COAM)IBA 11/2010
1	PolymersIBA 11/2010
1	Polysaccharides (Glycans)IBA 11/2010
1	CitrullineIBA 09/2010
1	serum P-component (CIt)IBA 09/2010
1	Protein-Arginine DeiminasesIBA 09/2008
1	Chemokine CXCL6IBA 12/2007
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 06/2007
1	Messenger RNA (mRNA)IBA 06/2007
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2006
1	CXC ChemokinesIBA 01/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006
1	Interferon-alpha (Interferon Alfa)IBA 01/2006
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2006
1	Chemokine CCL18IBA 11/2003

Therapy/Procedure

4	Therapeutics 01/2020 - 12/2007
1	Artificial Respiration (Mechanical Ventilation) 11/2022
1	Investigational Therapies (Experimental Therapy) 04/2018